Carbimazole
- Generic Name
- Carbimazole
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C7H10N2O2S
- CAS Number
- 22232-54-8
- Unique Ingredient Identifier
- 8KQ660G60G
- Background
An imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity.
- Indication
For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy.
- Associated Conditions
- Hyperthyroidism
- Associated Therapies
- -
Antithyroid Drug Treatment of Thyrotoxicosis in Young People
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-20
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
- Target Recruit Count
- 81
- Registration Number
- NCT01436994
- Locations
- 🇬🇧
Royal Hospital for Sick Children, Glasgow, United Kingdom
🇬🇧Hereford Hospital, Hereford, United Kingdom
🇬🇧St Bart's Hospital, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath